Apr 02, 2012
Biosimilars: Surveying the Market Landscape Report - This report reviews all aspects of biosimilar production, from manufacturing and marketing to the regulatory landscape.
Mar 15, 2012
Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report
Mar 15, 2012
Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report
Mar 14, 2012
Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations
Jan 09, 2012
This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.
Nov 30, 2011
New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD
Oct 25, 2011
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects
Oct 14, 2011
Just Published Report on Cytokine-Based Therapies and Inhibitors: R&D Pipelines, Markets, and Strategic Issues
Sep 22, 2011
View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.
Aug 04, 2011
Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.